| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Absolute Bioavailability, Pharmacokinetics, and Urinary Excretion of the Novel Antimigraine Agent Almotriptan in Healthy Male Volunteers
|
Jansat, Josep M.
|
|
2002
|
42 |
12 |
p. 1303-1310
|
article
|
| 2 |
Bleeding Associated with Eptifibatide Targeting Higher Risk Patients with Acute Coronary Syndromes: Incidence and Multivariate Risk Factors
|
Rasty, Saeed
|
|
2002
|
42 |
12 |
p. 1366-1373
|
article
|
| 3 |
Clinical Manifestation of Atherosclerotic Peripheral Arterial Disease and the Role of Cilostazol in Treatment of Intermittent Claudication
|
Crouse, John Robert
|
|
2002
|
42 |
12 |
p. 1291-1298
|
article
|
| 4 |
Effect of Dietary Fat Content in Meals on Pharmacokinetics of Quazepam
|
Yasui-Furukori, Norio
|
|
2002
|
42 |
12 |
p. 1335-1340
|
article
|
| 5 |
Integrated Pharmacokinetic/Pharmacodynamic Model of XV459, a Potent and Specific GpIIb/IIIa Inhibitor, in Healthy Male Volunteers
|
Fossler, Michael J.
|
|
2002
|
42 |
12 |
p. 1326-1334
|
article
|
| 6 |
Microsomal Enzyme Induction and Clinical Aggravation of Porphyria: The Evaluation of Human Urinary 6β-Hydroxycortisol/Cortisol Ratio as the Index of Hepatic CYP3A4 Activity
|
Uejima, Etsuko
|
|
2002
|
42 |
12 |
p. 1374-1379
|
article
|
| 7 |
No Effect of Rosuvastatin on the Pharmacokinetics of Digoxin in Healthy Volunteers
|
Martin, Paul D.
|
|
2002
|
42 |
12 |
p. 1352-1357
|
article
|
| 8 |
No Effect of the Novel Antidiabetic Agent Nateglinide on the Pharmacokinetics and Anticoagulant Properties of Warfarin in Healthy Volunteers
|
Anderson, Denise M.
|
|
2002
|
42 |
12 |
p. 1358-1365
|
article
|
| 9 |
Pharmacokinetic and Safety Assessments of Galantamine and Risperidone after the Two Drugs Are Administered Alone and Together
|
Huang, Fenglei
|
|
2002
|
42 |
12 |
p. 1341-1351
|
article
|
| 10 |
Pharmacokinetics and Safety of a Single Oral Dose of Once-Daily Alfuzosin, 10 mg, in Male Subjects with Mild to Severe Renal Impairment
|
Marbury, Thomas C.
|
|
2002
|
42 |
12 |
p. 1311-1317
|
article
|
| 11 |
Pioglitazone: Effect on CYP3A4 Activity
|
Nowak, Sandra N.
|
|
2002
|
42 |
12 |
p. 1299-1302
|
article
|
| 12 |
The Pharmacokinetics of Toborinone in Subjects with Congestive Heart Failure and Concomitant Renal Impairment and/or Concomitant Hepatic Impairment
|
Tammara, Brinda
|
|
2002
|
42 |
12 |
p. 1318-1325
|
article
|
Journal description